Yayın:
Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMelih Z. Kaya
dc.contributor.authorYakup Gültekin
dc.contributor.authorM. Çelebier
dc.contributor.authorMurat Soyseven
dc.contributor.authorİmran Vural
dc.contributor.authorLevent Öner
dc.contributor.authorAyata Cenk
dc.contributor.authorSibel Bozdağ Pehlivan
dc.contributor.authorAndrea M. Harriott
dc.contributor.orcid0000-0001-6504-0757
dc.contributor.orcid0000-0002-6433-2392
dc.contributor.orcid0000-0001-5066-2772
dc.contributor.orcid0000-0003-0417-7586
dc.date.accessioned2026-05-20T10:20:04Z
dc.date.issued2026-03-05
dc.identifier.doi10.1016/j.ijpharm.2026.126743
dc.identifier.endpage126743
dc.identifier.issn0378-5173
dc.identifier.openalexW7133649980
dc.identifier.startpage126743
dc.identifier.urihttps://hdl.handle.net/11421/39790
dc.identifier.urihttps://doi.org/10.1016/j.ijpharm.2026.126743
dc.identifier.volume694
dc.language.isoen
dc.relation.ispartofInternational Journal of Pharmaceutics
dc.rightsopenAccess
dc.subjectRizatriptan
dc.subjectSumatriptan
dc.subjectNasal administration
dc.subjectCalcitonin gene-related peptide
dc.subjectTriptans
dc.subjectMigraine
dc.subjectIn vivo
dc.subject.sdg3
dc.titleIntranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications